Cargando…

Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment

Neurocognitive disorders are frequent among chronic kidney disease (CKD) patients. Identifying and characterizing cognitive impairment (CI) can help to assess the ability of adherence to CKD risk reduction strategy, identify potentially reversible causes of cognitive decline, modify pharmacotherapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pépin, Marion, Ferreira, Ana Carina, Arici, Mustafa, Bachman, Maie, Barbieri, Michelangela, Bumblyte, Inga Arune, Carriazo, Sol, Delgado, Pilar, Garneata, Liliana, Giannakou, Konstantinos, Godefroy, Olivier, Grodzicki, Tomasz, Klimkowicz-Mrowiec, Aleksandra, Kurganaite, Justina, Liabeuf, Sophie, Mocanu, Carmen Antonia, Paolisso, Giuseppe, Spasovski, Goce, Vazelov, Evgueniy Stefanov, Viggiano, Davide, Zoccali, Carmine, Massy, Ziad A, Więcek, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713156/
https://www.ncbi.nlm.nih.gov/pubmed/34718757
http://dx.doi.org/10.1093/ndt/gfab262
Descripción
Sumario:Neurocognitive disorders are frequent among chronic kidney disease (CKD) patients. Identifying and characterizing cognitive impairment (CI) can help to assess the ability of adherence to CKD risk reduction strategy, identify potentially reversible causes of cognitive decline, modify pharmacotherapy, educate the patient and caregiver and provide appropriate patient and caregiver support. Numerous factors are associated with the development and progression of CI in CKD patients and various conditions can influence the results of cognitive assessment in these patients. Here we review clinical warning signs that should lead to cognitive screening; conditions frequent in CKD at risk to interfere with cognitive testing or performance, including specificities of cognitive assessment in dialysis patients or after kidney transplantation; and available tests for screening and observed cognitive patterns in CKD patients.